Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
7.90
+0.01 (0.13%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 619 employees as of December 31, 2024. The number of employees decreased by 90 or -12.69% compared to the previous year.
Employees
619
Change (1Y)
-90
Growth (1Y)
-12.69%
Revenue / Employee
$289,107
Profits / Employee
-$257,661
Market Cap
1.17B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ADPT News
- 17 days ago - Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewsWire
- 20 days ago - Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma - GlobeNewsWire
- 6 weeks ago - Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies Corporation (ADPT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025 - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients - GlobeNewsWire